Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Soliman

Showing results (1141-1150 of 1,227) with videos related to

Pageof 123
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|June 9, 2023
Activin A-Expressing Polymorphonuclear Myeloid-Derived Suppressor Cells Infiltrate Skeletal and Cardiac Muscle and Promote Cancer CachexiaKasia Dzierlega, Mainak Chakraborty, Megan Lee, et al.
Dermatology and Therapy|February 5, 2025
Real-World Effectiveness of Risankizumab in Patients with Moderate-to-Severe Psoriasis: Interim Analysis from the VALUE Global Prospective Post-marketing Observational Study at 25 MonthsDiamant Thaçi, Mamitaro Ohtsuki, Julia-Tatjana Maul, et al.
Current Microbiology|July 24, 2023
Intra-clade Heterogeneity in Candida auris: Risk of ManagementBahgat Fayed, Imene K Lazreg, Razan B AlHumaidi, et al.
Cureus|November 25, 2025
Letournel-Judet Classification of Acetabular Fractures: A Systematic Review of Reliability and Association With Post-traumatic ArthritisAbdelrahman Sahnon Abaker Sahnon, Ahmed Atef Ramadan Mostafa Ali, Amr M Soliman, et al.
Science Advances|June 18, 2019
Anti-CotH3 antibodies protect mice from mucormycosis by prevention of invasion and augmenting opsonophagocytosisTeclegiorgis Gebremariam, Sondus Alkhazraji, Sameh S M Soliman, et al.
Rheumatology and Therapy|March 18, 2024
Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the KEEPsAKE 2 Randomized Clinical TrialAndrew Östör, Filip Van den Bosch, Kim Papp, et al.
Environmental Pollution (Barking, Essex : 1987)|June 18, 2023
Exposure to pyrogallol impacts the hemato-biochemical endpoints in catfish (Clarias gariepinus)Mohamed Hamed, Christopher J Martyniuk, Rashad E M Said, et al.
Renal Failure|March 28, 2023
Is the combination of linagliptin and allopurinol better prophylaxis against post-contrast acute kidney injury? A multicenter prospective randomized controlled studyAhmed Fayed, Ahmed A Hammad, Dina O Abdulazim, et al.
American Journal of Clinical Dermatology|July 29, 2025
Long-Term Safety and Efficacy of Risankizumab to Treat Moderate-to-Severe Plaque Psoriasis: Final LIMMitless Phase 3, Open-Label Extension Trial ResultsKim A Papp, Mark G Lebwohl, Lluís Puig, et al.
Journal of Eating Disorders|May 1, 2025
The weight of words: investigating the role of weight stigma and body mass index in shaping children and youth's emotional experiencesAbdelaziz Hendy, Sahar M Soliman, Hyam Tantawi, et al.
Pageof 123

Showing results (1141-1150 of 1,227) with videos related to

Sort By:
Pageof 123
Journal of Immunology (Baltimore, Md. : 1950)|June 9, 2023
Activin A-Expressing Polymorphonuclear Myeloid-Derived Suppressor Cells Infiltrate Skeletal and Cardiac Muscle and Promote Cancer CachexiaKasia Dzierlega, Mainak Chakraborty, Megan Lee, et al.
Dermatology and Therapy|February 5, 2025
Real-World Effectiveness of Risankizumab in Patients with Moderate-to-Severe Psoriasis: Interim Analysis from the VALUE Global Prospective Post-marketing Observational Study at 25 MonthsDiamant Thaçi, Mamitaro Ohtsuki, Julia-Tatjana Maul, et al.
Current Microbiology|July 24, 2023
Intra-clade Heterogeneity in Candida auris: Risk of ManagementBahgat Fayed, Imene K Lazreg, Razan B AlHumaidi, et al.
Cureus|November 25, 2025
Letournel-Judet Classification of Acetabular Fractures: A Systematic Review of Reliability and Association With Post-traumatic ArthritisAbdelrahman Sahnon Abaker Sahnon, Ahmed Atef Ramadan Mostafa Ali, Amr M Soliman, et al.
Science Advances|June 18, 2019
Anti-CotH3 antibodies protect mice from mucormycosis by prevention of invasion and augmenting opsonophagocytosisTeclegiorgis Gebremariam, Sondus Alkhazraji, Sameh S M Soliman, et al.
Rheumatology and Therapy|March 18, 2024
Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the KEEPsAKE 2 Randomized Clinical TrialAndrew Östör, Filip Van den Bosch, Kim Papp, et al.
Environmental Pollution (Barking, Essex : 1987)|June 18, 2023
Exposure to pyrogallol impacts the hemato-biochemical endpoints in catfish (Clarias gariepinus)Mohamed Hamed, Christopher J Martyniuk, Rashad E M Said, et al.
Renal Failure|March 28, 2023
Is the combination of linagliptin and allopurinol better prophylaxis against post-contrast acute kidney injury? A multicenter prospective randomized controlled studyAhmed Fayed, Ahmed A Hammad, Dina O Abdulazim, et al.
American Journal of Clinical Dermatology|July 29, 2025
Long-Term Safety and Efficacy of Risankizumab to Treat Moderate-to-Severe Plaque Psoriasis: Final LIMMitless Phase 3, Open-Label Extension Trial ResultsKim A Papp, Mark G Lebwohl, Lluís Puig, et al.
Journal of Eating Disorders|May 1, 2025
The weight of words: investigating the role of weight stigma and body mass index in shaping children and youth's emotional experiencesAbdelaziz Hendy, Sahar M Soliman, Hyam Tantawi, et al.
Pageof 123